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There are many causes of vitamin D deficiency, which determines pathogenesis 
of many diseases, including periodontal ones. Constant low uptake or deficiency of 
vitamin D results in progression of periodontal diseases and jaw bone metabolism 
- leads to change of bone mineral density, causes resorption in alveolar bone, tooth 
loss, changes of masticatory function and osteoporosis. The clinical studies strive 
to link vitamin D with gingivitis and periodontitis and prove its therapeutic and 
preventive role, because of vitamin D immunomodulatory, anti-inflammatory and 
antiproliferative effects for periodontal tissues and best treatment outcome. The 
purpose of this chapter is to analyze the importance of vitamin D on the pathogene-
sis of periodontal diseases, its role on regulation of the immune system and defense 
mechanism, influence on jawbone quality and on the correlation between vitamin 
D concentration in plasma and periodontal diseases.
Keywords: vitamin D, vitamin D deficiency, periodontal disease, jawbone,  
bone mineral density
1. Introduction
One billion people on the planet were diagnosed with vitamin D deficiency 
during the last decade [1]. Opinion, advocating important role of vitamin D and 
its deficiency in significant number of individuals, prevails within the society, a 
lot of information is available regarding its use, doses, sources, etc. However, each 
individual may have different vitamin D needs and the consumption of it should 
be monitored by testing individual serum levels of D2 (of alimentary origin) and 
D3 (synthesized in the skin), thus evaluating total level of vitamin D [2]. There are 
many causes of vitamin D deficiency, which is finally diagnosed if serum level of 
25OHD3 is less than 20 ng/mL [3, 4]. This determines pathogenesis of many dis-
eases, including periodontal ones, resulting in loss of masticatory function.
Periodontium (PT) consists of gingiva, periodontal ligament, cementum and 
alveolar bone. This is functional unit, maintaining homeostasis – the connection 
between tooth and gingiva makes up a unified whole, preventing penetration of 
microorganisms, chemical substances, capable to induce inflammation of periodon-
tal tissues (PTs). The periodontal ligament and bone keep tooth inside the alveolar 
socket, distribute mechanical load of mastication. PT has its own blood supply, 
neural regulation and defensive mechanisms. Soft and mineralized dental plaque is 
initiative risk factor of periodontal diseases (PD) – bacterial biofilm and its adhesion 
to tooth surface induces response of PTs, but in general, diseases are caused by many 
predisposing factors. PD initially manifest as gingivitis, which, if untreated, spreads 
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deeper within PT: causing attachment loss, periodontal pocket formation, alveolar 
bone resorption and tooth loss over time [5, 6]. Increasing number of studies proves 
importance of vitamin D in prevention and management of oral diseases [7]. Clinical 
studies strive to link vitamin D with PD and prove its therapeutic and preventive 
role. Vitamin D is secosteroidal hormone, playing important role in the treatment 
of gingivitis and periodontitis because of its anti-inflammatory and antibacterial 
effect on PTs as well as its immunomodulatory, differentiating, anti-proliferative and 
regulative effect on autoimmune processes, cellular apoptosis and participation in 
bone metabolism [3, 7–10]. Disintegration and renewal processes of bone depend on 
metabolism, as constant interchange of mineral substances between bone and blood 
plasma, where an active form of vitamin D is circulating, takes place [11]. One of the 
main functions of vitamin D is maintaining of blood levels of calcium and phospho-
rus by regulating absorption of these substances inside the bowels and reabsorption 
in kidneys and by enhancing remodeling processes [12, 13]. Bone is like a living and 
continuously changing organ where resorption and regeneration, i.e. remodelation, 
take place [14]. For this reason, the old bone is not accumulating and adaptation to 
changing mechanical forces develops. Jawbone support the teeth in alveolar sockets, 
skeletal bones protect internal organs and acts as depot of mineral substances espe-
cially calcium (also is necessary for normal muscle function) [15]. Osteoporotic (OP) 
changes of skeletal bones occur because of impaired mineralization due to long term 
decreased uptake of vitamin D and calcium, increasing risk of fractures, accelerated 
jawbone resorption causes adentia [16, 17].
2. Vitamin D metabolism
There are 4 forms of vitamin D (calciferol) – lamisterol (vit. D1), ergocalciferol 
(vit. D2), cholecalciferol (vit. D3) and dihydrotachysterol (vit. D4), 2 of which being 
the most important – D2 and D3. Under the influence of UV radiation, ergosterol 
(plant based) and cholesterol (synthetized from 7-dehydrocholesterol of animal 
origin) are transformed into vitamin D2 and D3 respectively [1, 18]. Major part of 
vitamin D, around 90%, is synthesized in epidermis under the effect of the sun, 
while the rest is absorbed in small intestine together with food, nowadays being 
enriched with vitamin D with increasing frequency [19, 20]. Hydroxylation of 
vitamin D is a two-stage process, taking place in liver and kidneys. Thus renal and 
liver diseases impair metabolism of vitamin D. Enzyme 25-hydroxylase trans-
forms vitamin D3 into 25-hydroxyvitamin D3 25(OH)D3 in liver, which is the main 
metabolite of vitamin D3, circulating in blood [21]. Recently it was proved that 
when inflammation occurs gingival fibroblasts and periodontal cells  are capable of 
producing 25-hydroxylase and it appears to be a new extrahepatic site of 25(OH)D3 
synthesis [21]. Further, 25-hydroxyvitamin D3 is hydroxylated in kidneys by means 
of 1 α-hydroxylase into 1,25-dihydroxyvitamin D (1,25(OH)2D3), calcitriol, active 
form of vitamin D, which is active hormone, participating in calcium absorption in 
intestines, important for both specific and nonspecific immune response against 
bacterial infections of oral cavity and other organs [2, 7, 21, 22]. Calcitriol binds to 
vitamin D-binding protein (DBP) and is transported to the cells of target tissues 
[23]. Synthesis of 1α-hydroxylase starts after receptors of cellular membranes have 
been influenced by microorganisms. Calcitriol is activated after binding to vitamin 
D receptors (VDR) of nuclei of immune and epithelial cells [7, 23–25]. VDR can 
be found in many human tissues, regulating activity of more than 200 genes in 
direct or indirect way [26, 27]. Numerous distribution of VDR in tissues determines 
complex effect of vitamin D, whereas deficiency determines disorders [26–28]. 
Polymorphism of VDR gene is related to many infectious diseases, including PD 
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[28–30]. Polymorphism of VDR gene and exact mechanism of periodontitis remain 
unclear so far. There is no link established between polymorphism of VDR genes 
and aggressive form of periodontitis [31, 32].
3. The role of vitamin D in immune response of periodontal tissues
Marginal gingival epithelium (GE) descends from free inner margin towards 
root apex and transits to sulcular epithelium – semi permeable membrane. Sulcular 
epithelium attaches to tooth by means of loose connections, creating favorable 
 conditions for bacterial invasion from dental plaque [33]. Thin and non-keratinized 
epithelium forms a junctional epithelium (JE), laying at the bottom of gingival 
sulcus. JE is a narrow structure of 1–2 mm with good regenerative properties, 
connected to tooth by layer of organic substance. Its cubic and flat cells have gaps 
and attach to tooth and with each other by means of hemidesmosoms and have 
2 basal membranes: internal, near the tooth, and the outer one on the other side, 
contacting with subepithelial tissue. Disruption of the bonds between enamel 
cuticle and JE leads to inflammatory processes. This anatomical unit plays a barrier 
function, which is supported by gingival fluid, flushing gingival sulcus – blood 
filtrate, containing lots of various protective cells (neutrophilic leucocytes, lympho-
cytes, monocytes, and macrophages), specific antibodies, immunoglobulins, cyto-
kines, proteins, enzymes, epithelial cells and bacteria. The amount of gingival fluid 
can change due to circadian rhythms and depends on the health of PTs, oral hygiene, 
mechanic impact while mastication, medications used, etc. [34, 35]. Plasma proteins 
strengthen junctional epithelium-enamel bonds and namely calcitriol, affecting 
nonspecific immunity, activates synthesis of proteins, necessary for small adherens, 
gap and desmosome epithelium intercellular junctions, activates hydrogen peroxide 
secretion in monocytes, stimulates the synthesis of antimicrobial peptides, che-
motaxis, production of cytokines and chemokines, cellular reproduction, vascular 
permeability, wound healing, and neutralization of bacterial endotoxins [7, 25, 36]. 
Hence 1,25(OH)2D3 enhances antibacterial defense of GE [25, 36, 37].
Immune response can be nonspecific and specific. After bacteria have entered 
the periodontal tissues, defensive mechanism starts – immune response, dur-
ing which the foreign substance is neutralized and eliminated or memorized. 
Neutrophilic leucocytes play important role in nonspecific immune response. It is 
interesting, that these cells are always found in gingival sulcus and this is the only 
site in organism, where neutrophilic leucocytes can freely migrate from organism 
outwards. During the bacterial invasion into PTs, chemotactic mechanisms are acti-
vated and neutrophilic leucocytes start migrating from blood vessels into inflamed 
tissues. Right here, together with macrophages, they take part in phagocytosis, thus 
fighting with different antigens. Neutrophilic leucocytes, monocytes and activated 
macrophages produce immune mediators (IL-1β, IL-1ra, IL-6, IL-10, IL-12, TNF-α, 
PGE2, MMP, Interferon γ (IFNγ)) and chemokines [37]. Vitamin D protects the 
organism from excessive immune response by decreasing the secretion of IL-1, 
IL-6, IL-8, IL-12, TNF-α cytokines, decreases production of matrix metalloprotein-
ase (MMP) in leucocytes [33, 38]. MMP – enzymes, participating in alterations of 
intercellular tissues. Blood plasma levels of MMP-3, MMP-8 and MMP-9 increase 
with PD [39]. Very high level of MMP-9 is detected in cases of rapidly progressing 
periodontitis, but it can decrease up to 69% taking even little doses of vitamin D for 
extended period of time [40, 41].
Blood monocytes, after migration into connective tissues, transform into mac-
rophages, which are very important for both, cellular and humoral immunity, as 
they have surface receptors, reacting with any foreign substance [42]. In the process 
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of phagocytosis, immunoglobulins and serum complement envelope foreign 
substance. Such formation enters phagocytic vacuoles and is destroyed by lysosome 
enzymes. Afterwards these substances are transferred to lymphocytes, determin-
ing further immune response [42]. Products of tissue breakdown, histamine and 
complement system enhances phagocytosis. Specific immune response manifests 
later. Antibodies circulate in blood, T and B lymphocytes react only to specific 
antigen. Lymphocytes are often related to Langerhans cells of oral epithelium, pro-
ducing cytokines, e.g., IL-1, activating T lymphocytes, enhancing proliferation and 
production of antibodies. Active T lymphocytes have cytotoxic effect. Keratinocytes 
of oral epithelium produce IL-1 and IL-8, regulating the amount of lymphocytes 
and polymorphonuclear leucocytes [42]. Impaired specific immunity is responsible 
for resorption, osteoclast genesis and inflammatory processes of bone, thus causing 
autoimmune diseases. Calcitriol suppresses progression of OP and PD with signs of 
autoimmune diseases.
Active hormonal form of vitamin D, 1,25(OH)2D3, directly regulates antimicro-
bial immune response, modulates cytokine production and stimulates secretion of 
antimicrobial peptides by monocytes-macrophages and activates release of hydro-
gen peroxide in monocytes, thus exhibiting anti-inflammatory and antimicrobial 
properties [7, 43, 44]. Monocytes not only produce cytokines, but TNF-α as well, 
they release substances, activating lymphocytes and interacting with them as anti-
gen-presenting cell (APC), destroy PTs, accelerate proliferation, differentiation 
and activation of osteoclasts, move in tissues in chemotactic way and participate in 
phagocytosis. Antimicrobial peptides play important role in nonspecific immunity 
against periodontitis causing agents. Antimicrobial peptides, β-defensines and 
especially cathelicidine LL-37 take part in neutralization of bacterial endotoxins, 
healing of wounds, regulate cell multiplication, blood vessel permeability, cytokine 
and chemokine production and chemotaxis, have prolonged antimicrobial activity 
and neutralize lipopolysaccharides as well [3, 7, 23, 25, 45, 46]. Activity of defen-
sines depends on vitamin D levels [45, 46]. β-defensines show antimicrobial activ-
ity on PD bacteria– Actinobacilus actinomycetemcomitans, Porphyromonas gingivalis, 
Fusobacterium nucleatum, Candida and papilloma viruses [47]. APCs, including 
macrophages and dendritic cells, transform the main 25(OH)D3 form circulating in 
blood into active 1,25(OH)2D3, and, via VDR, induce cellular response and regulate 
transcription. Antimicrobial activity via VDR is associated with cathelicidine 
hCAP-18 gene [48]. Cathelicidine has wide antimicrobial activity against gram-
positive and gram-negative bacteria, some fungi and viruses [3]. Treatment with 
vitamin D increases cathelicidine mRNA level in keratinocytes, neutrophils and 
macrophages [3, 44]. Irritation of macrophage receptors with pathogens increases 
synthesis of 1,25(OH)2D3, activity in macrophages and production of antibacterial 
proteins, cathelicidine and β-defensines, increases [43]. Therefore, it is supposed 
that vitamin D deficiency determines weak antibacterial response and tendency to 
infections [49].
During specific immune response, 1,25(OH)2D3 affects B and T lymphocytes 
[7]. The latter release cytokines (interleukine-1, TNF-α, macrophage activat-
ing factor, macrophage migration inhibitory factor), stimulating resorption of 
dental supportive tissues (due to increased number of osteoclasts) and decay of 
extracellular matrix; release immunoglobulins; destroy pathogens, transferred by 
macrophages and dendritic cells and participate in production of antibodies. Such 
immune response mechanism enhances pathogenesis of PTs and aggravates the 
course of disease [16, 21, 33]. 1,25(OH)2D3 suppresses proliferation, maturation 
and differentiation of dendritic cells [50]. T lymphocytes are one of the dominat-
ing cells in the beginning of PTs pathologic process and its regulator; immature 
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dendritic cells stimulate their tolerance, whereas mature dendritic cells activate 
them [51]. 1,25(OH)2D3 decreases the number of APCs and ability of T lymphocyte 
to stimulate monocytes-macrophages [52]. The main target is T helpers. Vitamin 
D can contribute to formation of acquired immune response by selective stimula-
tion of the specific T helpers [53]. B lymphocytes interact with macrophages and 
become plasmocytes, releasing Ig, which adhere to antigens. Such antigen–anti-
body complex activates complement system, initiating production of cytotoxic 
molecules, increasing blood vessel permeability, acting as chemotactic agents for 
polymorphonuclear leucocytes and macrophages. Vitamin D inhibits T lymphocyte 
proliferation, release of immunoglobulins and transformation of B lymphocytes 
into plasmocytes, hereby suppressing specific immune response, release of IL-1, 
IL-6, IL-8, IL-12 cytokines and alpha TNF-α [16, 21, 52]. IL-1, IL-6 and TNF-α are 
potential activators of osteoclasts and supporters of inflammation. IL-1 is released 
not only by afore mentioned monocyte-macrophages, but by endothelial and epi-
thelial cells, fibroblasts and lymphocytes as well. This substance supports inflama-
tion, stimulates production, differentiation and activation of osteoclasts, leading to 
resorption of alveolar bone, release of enzymes splitting extracellular matrix and 
release of E2 prostaglandin, enhancing relaxation of blood vessels and edema in PTs 
[13]. IL-6 activates synthesis of C reactive protein and glucose metabolism [54]. It is 
proven, that increase of vitamin D serum levels leads to decrease of IL-6 and leptin 
(factor indicating inflammation) levels, increase of adiponectin (cytokine inhibi-
tor) and IL-8 levels [54, 55]. IL-8 activates neutrophil chemotaxis and is found in 
normal PTs. Its levels increase with the progression of inflammatory processes, 
therefore polymorphonuclear neutrophils are the first to react to inflammation. Its 
deficiency is related to severe forms of periodontitis. As the amount of pathogens 
increases, IL-8 levels and number of neutrophils increase as well, causing destruc-
tion of PTs [6]. Vitamin D acts on periopathogens, inhibits inflammation of PT and 
decreases IL-8 expression in periodontal ligament [55]. It can be concluded, that 
vitamin D plays important role in defensive mechanisms of PT and vital for the 
health of both soft and hard PTs.
4.  Change in the concentration of 25-hydroxyvitamin D in plasma by 
periodontal diseases
There is no unanimous attitude towards the relation between these two factors 
as there exist differences between populations, test methodology and occurring 
limitations of the tests. When analyzing the relation between vitamin D, as protec-
tive factor, and PD, different criteria of vitamin D and examination of PTs are 
applied: average plasma level of vitamin D, dosage applied or any other certain 
diagnostic criteria. Status of PTs is evaluated according to the periodontal pocket 
depth, clinical attachment level, clinical attachment loss, attachment gain, alveolar 
bone loss, bone defects in oral cavity or any other selected criteria, such as short/
long term results of periodontal surgery [56]. If only one side of oral cavity is 
examined, data cannot be accurate and the amount of information is lost. Studies 
can cover general population or part of it, e.g., smoking individuals, individuals of 
different age, with different PD, etc. Scientific base of linking these two factors and 
widening of the knowledge is possible due to widely chosen evaluative protocols 
and indicators. For example, smoking is risk factor for PD, but with the additional 
deficiency of vitamin D, destruction of PTs is more severe and more cases are 
identified [57]. Individuals over 50 year with low vitamin D levels have greater 
periodontal attachment loss than ones with high levels [58]. PTs in most cases are 
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healthier and risk is lower in individuals with sufficient levels of vitamin D, but it is 
not successfully proved in all the cases, leading to the controversial interpretation 
of the results obtained [56, 58–61]. It is becoming clear, that performing blood tests 
and monitoring vitamin D levels it is possible to suspect that individual is suffering 
from chronic periodontitis and condition of PTs is poor, especially in older popula-
tion [56, 62, 63]. It can be one of additional diagnostic possibilities.
In case of acute inflammation, serum levels of 25-hydroxyvitamin D are 
increasing, as periodontal cells are producing it in the site of inflammation as 
anti-inflammatory agent. Serum levels of 25-hydroxyvitamin D usually are lower 
in cases of chronic inflammation. Such correlation might be explained that because 
of low serum levels of vitamin D, ability of epithelium to fight against pathogens is 
impaired and inflammation develops. Optimal serum level of 25-hydroxyvitamin 
D for prophylactic and therapeutic purposes should be 90-100 nmol/l, but it is 
not definitely clear what should be the daily dose of vitamin D in order to achieve 
these levels [13]. Gingival bleeding are the sign of both, acute and chronic PD. 
Decreased level of 25-hydroxyvitamin D correlates with worsened health status of 
PTs; course of chronic gingivitis (with insufficient serum levels) and intensified 
gingival bleeding [36, 58]. Gingival bleeding during the probing is observed by 
20% less in patients with high serum levels of 25(OH)D, those with sufficient (≥ 
50 nmol/L) levels of vitamin are less likely to develop PD by 33% and by 42% are 
less likely to have more than 50% of gingival bleeding [60, 64]. Prolonged com-
bined supplementation of vitamin D and calcium decreases bleeding on probing, 
changes the clinical attachment level and pockets depth [65]. The tendency to 
severe periodontitis may decrease up to 33% with daily dose of 800 IU of vitamin 
D [62]. Exacerbation of gingival bleeding is observed during pregnancy, thus there 
are data, concerning the influence of vitamin D during this period (if 25(OH)
D level < 75 nmol/L) [36]. Without timely evaluation of all these data, peri-
odontitis of more severe form develops, as correlation between increased serum 
levels of vitamin D3 and severity of PD exists, though it is not always confirmed 
[36, 66, 67]. There are cases described when serum level of 1,25(OH)D increases 
significantly following the periodontal treatment [68]. Besides, increased serum 
level of 25(OH)D is common in patients with aggressive periodontitis (AP)- dis-
ease of PTs, affecting young individuals, characterized by rapid destruction of 
PT and tooth loss. Significantly higher vitamin D binding protein (DBP), IL-6, 
procalctonine and 25(OH)D3 plasma levels and higher counts of leucocytes and 
neutrophils are found in patients with this PD [69]. Level of 25(OH)D3 increases 
due to activation of 25-hydroxylase in periodontal cells in acute inflammation of 
PTs, and decrease in chronic one [67]. Due to production of this enzyme in cases 
of AP, levels of 25(OH)D3 in gingival sulcus is up to 300 times higher than in 
blood plasma [21]. DBP is plasma protein and is synthesized by hepatocytes [70]. 
It is the main carrier of 25(OH)D3 in the plasma, directly affecting cellular func-
tions, including activity of macrophages [71, 72]. DBP bound to the cell surface, 
B-lymphocytes, T-lymphocytes, monocytes, neutrophils [70]. The amount of this 
protein is related to the severity degree of illness with direct relation to neutrophil 
– increased number of neutrophils and IL-6 can contribute to increased plasma 
levels of DBP by active periodontitis. DBP is the most important “during inflam-
mation since it induces selective recruitment of neutrophils” [70]. Activated 
neutrophils can excrete DBP, which expression is regulated by IL-6, participating 
in immune response [69]. Thus detection of plasma levels of DBP could confirm 
correlation between it and periodontal inflammation. Anti-inflammatory effect 
depends on the dose of vitamin supplement. Safe and effective anti-inflammatory 
dose of 500–2000 IU of vitamin D is recommended. Results are noted earlier when 
higher dose of 2000 IU is used [73].
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5. Conclusion
In conclusion, vitamin D is very unique substance due to its abilities, functions 
and participation in various processes. Its optimal serum levels could prevent 
occurrence of numerous diseases, including such common diseases throughout the 
world as chronic periodontal diseases, which are social problems, compromising 
individual’s quality of life.
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